Form S-3 COGNITION THERAPEUTICS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Cognition Therapeutics establishes $75 million stock offering program
December 18, 2025 4:22 PM ESTCognition Therapeutics Inc. (NASDAQ: CGTX) entered into an at-the-market equity offering agreement with Jefferies LLC on December 18, 2024, according to a company filing.
Under the sales agreement, Cognition Therapeutics may sell up to $75 million of its common stock through Jefferies, which will... More
Cognition Therapeutics, Inc. (CGTX) files $300M mixed shelf
December 18, 2025 4:09 PM ESTCognition Therapeutics, Inc. (NASDAQ: CGTX) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Subscription Rights
